Trial intelligence / Profile preview

Lithium in Bipolar I Disorder

NCT00422331Phase 3Unknown

Sponsor
JDS Pharmaceuticals
Start
Jan 2007
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 3 trial of lithium carbonate in bipolar I disorder, sponsored by JDS Pharmaceuticals. Status: unknown.

02

Drugs

lithium carbonate
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00422331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00422331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call